Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4

FEMS Microbiology Letters

Volumn 240, Issue 2, 2004, Pages 131-136

  You, Hyun Ju ^a   Oh, Deok Kun ^b   Ji, Geun Eog ^a,c  

^a Seoul National University   (South Korea)

^b Bifido Co   (South Korea)

^c Sejong University   (South Korea)

Author keywords

Bifidobacterium; Chiroinositol containing polysaccharide; Colon cancer; Growth inhibition; Probiotics

Indexed keywords

BROXURIDINE; INOSITOL DERIVATIVE; POLYSACCHARIDE; TRYPAN BLUE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BIFIDUM; CANCER CELL CULTURE; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BIFIDOBACTERIUM; BROMODEOXYURIDINE; CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; FECES; GALACTOSE; GLUCOSE; HUMANS; INOSITOL; POLYSACCHARIDES, BACTERIAL; RHAMNOSE; RIBOSE; TRYPAN BLUE;

BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM;

EID: 7644231876     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2004.09.020     Document Type: Article

References (30)

1. R. Fuller Probiotics in man and animals J. Appl. Bacteriol. 66 1989 365 378
2. B.R. Goldin Health benefits of probiotics Br. J. Nutr. 80 1998 S203 S207
3. S.L. Malhotra Dietary factors in a study of colon cancer from Cancer Registry, with special reference to the role of saliva, milk and fermented milk products and vegetable fibre Med. Hypotheses 3 1977 122 126
4. M.E. Sanders Development of consumer probiotics for the US market Br. J. Nutr. 80 1998 S213 S218
5. B.L. Pool-Zobel, C. Neudecker, I. Domizlaff, S. Ji, U. Schillinger, C. Rumney, M. Moretti, I. Vilarini, R. Scassellati-Sforzolini, and I. Rowland Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats Nutr. Cancer 26 1996 365 380
6. H. Arimochi, T. Kinouchi, K. Kataoka, T. Kuwahara, and Y. Ohnishi Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon Biochem. Biophys. Res. Commun. 238 1997 753 757
7. D.D. Gallaher, W.H. Stallings, L.L. Blessing, F.F. Busta, and L.J. Brady Probiotics, cecal microflora, and aberrant crypts in the rat colon J. Nutr. 126 1996 1362 1371
8. H. Abdelali, P. Cassand, V. Soussotte, M. Daubeze, C. Bouley, and J.F. Narbonne Effect of dairy products on initiation of precursor lesions of colon cancer in rats Nutr. Cancer 24 1995 121 132
9. M. Onoue, S. Kado, Y. Sakaitani, K. Uchida, and M. Morotomi Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats Cancer Lett. 113 1997 179 186
10. B.R. Goldin, L.J. Gualtieri, and R.P. Moore The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat Nutr. Cancer 25 1996 197 204
11. B.R. Goldin, and S.L. Gorbach Effect of Lactobacillus acidophilus dietary supplements in 1, 2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats J. Natl. Cancer Inst. 64 1980 263 265
12. I.R. Rowland, C.J. Rumney, J.T. Coutts, and L.C. Lievense Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats Carcinogenesis 19 1998 281 285
13. J. Singh, A. Rivenson, M. Tomita, S. Shimamura, N. Ishibashi, and B.S. Reddy Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis Carcinogenesis 18 1997 833 841
14. T. Kohwi, K. Imai, A. Tamura, and Y. Hashimoto Antitumor effect of Bifidobacterium infantis in mice Gann 69 1978 613 618
15. I. Kato, S. Kobayashi, T. Yokokura, and M. Mutai Antitumor activity of Lactobacillus casei in mice Gann 72 1981 517 523
16. K.M. Shahani, and A.D. Ayebo Role of dietary lactobacilli in gastrointestinal microecology Am. J. Clin. Nutr. 33 1980 2448 2457
17. R. Maclennan, and O.M. Jensen Dietary fibre, transit time, fecal bacteria, steroids, and colon cancer in two Scandinavian populations Lancet 30 1977 207 211
18. K. Sekine, J. Ohta, M. Onishi, T. Tatsuki, Y. Shimokawa, T. Toida, T. Kawashima, and Y. Hashimoto Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis Biol. Pharm. Bull. 18 1995 148 153
19. M. Oda, H. Hasegawa, S. Komatsu, M. Kambe, and F. Tsuchiya Anti-tumor polysaccharide from Lactobacillus sp Agric. Biol. Chem. 47 1983 1623 1625
20. N. Manjunath, and B. Ranganathan A cytotoxic substance produced by a wild culture of Lactobacillus casei D-34 against tumor cells Indian J. Exp. Biol. 27 1989 141 145
21. S.Y. Park, G.E. Ji, Y.T. Ko, H.K. Jung, Z. Ustunol, and J.J. Pestka Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium Int. J. Food Microbiol. 46 1999 231 241
22. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. and Strober, W. (1990) Trypan blue exclusion test of cell viability. In: Current Protocols in Immunology (John Wiley and Sons, eds.) vol. 2, p. A.3.3., Greene Publishing Associates and Wiley-Interscience, New York
23. M.-H. Coconnier, M.F. Bernet, S. Kerneis, G. Chauviere, J. Fourniat, and A.L. Servin Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion FEMS Microbiol. Lett. 110 1993 299 305
24. M. Pinto, S. Robine-Leon, M.D. Appay, M. Kedinger, N. Triadou, E. Dussaulx, B. Lacroix, P. Simon-Assmann, K. Haffen, J. Fogh, and A. Zweibaum Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture Biol. Cell 47 1983 323 330
25. I.H. Kim, M.S. Park, and G.E. Ji Characterization of adhesion of Bifidobacterium sp. BGN-4 to human enterocyte-like Caco-2 cells J. Microbiol. Biotechnol. 13 2003 276 281
26. T. Ebina Activation of antitumor immunity by intratumor injection of biological preparations Gan. To. Kagaku Ryoho 30 2003 1555 1558
27. H. Kado, Y. Yoneta, S. Takeo, M. Mitsui, and N. Watanabe Studies on an enzymatically synthesized antitumor polysaccharide SPR-901 Chem. Pharm. Bull. 39 1991 1078 1079
28. P. Dinadayala, A. Lemassu, P. Granovski, S. Cerantola, N. Winter, and M. Daffe Revisiting the structure of the anti-neoplastic glucans of Mycobacterium bovis bacille calmette-guomicron rin analysis of the different types of glucans produed by the vaccine substrains J. Biol. Chem. 279 2004 12369 12378
29. A. Hosono, J. Lee, A. Ametani, M. Natsume, M. Hirayama, T. Adachi, and S. Kaminogawa Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4 Biosci. Biotechnol. Biochem. 61 1997 312 316
30. J.Y. Kim, H.J. Woo, Y.S. Kim, K.H. Kim, and H.J. Lee Cell cycle dysregulation induced by cytoplasm of Lactococcus lactis ssp. lactis in SNUC2A, a colon cancer cell line Nutr. Cancer 46 2003 197 201